Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Loading
Home›
Research›
People›
Barry Lutz
AddedMar 31, 2024
UpdatedMay 31, 2026
Barry Lutz

Barry Lutz

Co-Founder, Aqueduct Critical Care

Crunchbase

Barry Lutz's Career

Aqueduct Critical Care
Aqueduct Critical Care

Bothell, WA, US

Co-Founder
Anavasi Diagnostics
Anavasi Diagnostics

Seattle, WA, US

Co-Founder

Create your profile now and gain access to exclusive deals and high-potential startups.

aVenture product preview
aVenture product preview
aVenture product preview

Barry Lutz's Career

Aqueduct Critical Care
Aqueduct Critical Care
Series A$6.8M302013Bothell, WA, US
Co-Founder

Leadership at Aqueduct Critical Care

Samuel BrowdSamuel BrowdCo-Founder
Eric BellEric BellBoard Member

Similar to Aqueduct Critical Care

BrainSpaceBrainSpaceBothell, WA, USMedical Devicesest. 2021BrainSpaceBothell, WA, US · est. 2021

BrainSpace: Collaborating to eliminate long-term handicaps from brain injuries.

Seed · $5.2M9
BeckerSmith MedicalBeckerSmith MedicalIrvine, CA, USMedical Devicesest. 2009BeckerSmith MedicalIrvine, CA, US · est. 2009

BeckerSmith Medical: Innovating CSF management with FLOWSAFE, a fully-automated, programmable system.

Angel · $150k2
InnerSpace NeuroSolutionsInnerSpace NeuroSolutionsTustin, CA, USMedical Devicesest. 2013InnerSpace NeuroSolutionsTustin, CA, US · est. 2013

Hummingbird ICP: Advanced monitoring tech for critical care, optimizing patient care & saving time.

Pre-Seed · $8.8M30
Anavasi Diagnostics
Anavasi Diagnostics
Seed$23.5M332021Seattle, WA, US
Co-Founder

Leadership at Anavasi Diagnostics

Robert AtkinsonRobert AtkinsonCo-Founder
Nelson PattersonNelson PattersonCEO
Minh DuongMinh DuongCo-Founder

Similar to Anavasi Diagnostics

NAT DiagnosticsNAT DiagnosticsSan Diego, CA, USDiagnostics, Medical Devicesest. 2014NAT DiagnosticsSan Diego, CA, US · est. 2014

NAT Diagnostics: Providing rapid, accurate point-of-care infectious disease testing since 2014.

Seed · $4.4M30
Minute Molecular DiagnosticsMinute Molecular DiagnosticsEvanston, IL, USDiagnostics, Medical Devicesest. 2017Minute Molecular DiagnosticsEvanston, IL, US · est. 2017

Minute Molecular Diagnostics: Rapid, innovative immunoassay device provider, founded in 2017.

Series B · $22.6M7
Prompt DiagnosticsPrompt DiagnosticsBaltimore, MD, USDiagnostic TestsPrompt DiagnosticsBaltimore, MD, US

Prompt Diagnostics: Rapid, affordable, and precise biotech firm for easy-to-use diagnostic testing.

Pre-Seed · $600k2

Barry Lutz's Similar Executives & Operators

Achmad ZakyAchmad ZakyCo-Founder · BukalapakNugroho HerucahyonoNugroho HerucahyonoCo-Founder · BukalapakBo ZhangBo ZhangCo-Founder · DiDiWILL WEI CHENGWILL WEI CHENGCo-Founder · DiDiDhirubhai H. AmbaniDhirubhai H. AmbaniFounder · Reliance RetailKim Beom-sooKim Beom-sooCo-Founder · KakaoBrian KimBrian KimCo-Founder · KakaoJB LEEJB LEECo-Founder · Kakao

People Similar to Barry Lutz

Peter CavanaghPeter CavanaghFounder · JointMetrix MedicalWarren BoekerWarren BoekerBoard Member · University of WashingtonMija HublerMija HublerCo-Founder · Prometheus MaterialsAleksander S. PopelAleksander S. PopelCo-Founder · AsclepiX TherapeuticsLutz TautzLutz TautzCo-Founder · Camino PharmaGary H. BernsteinGary H. BernsteinCo-Founder · Indiana Integrated Circuits